Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
842.9 INR | +0.72% | +0.12% | +43.99% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 169.3 | 74.41 | 73.18 | 193.8 | 281.9 | 1,345 |
Enterprise Value (EV) 1 | 385.7 | 174 | 55.22 | 105.7 | 283.5 | 1,640 |
P/E ratio | 23.6 x | 4.75 x | 6.77 x | 11.4 x | 29.2 x | 6.49 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.08 x | 1.09 x | 1.19 x | 4.1 x | 9.89 x | 1.15 x |
EV / Revenue | 4.73 x | 2.55 x | 0.9 x | 2.24 x | 9.95 x | 1.41 x |
EV / EBITDA | 8.82 x | 4.09 x | 2.13 x | 3.4 x | 14.4 x | 35.4 x |
EV / FCF | 3.95 x | 10.1 x | 0.2 x | -0.48 x | 1.33 x | -4.24 x |
FCF Yield | 25.3% | 9.92% | 500% | -207% | 74.9% | -23.6% |
Price to Book | 0.29 x | 0.13 x | 0.12 x | 0.31 x | 0.44 x | 0.57 x |
Nbr of stocks (in thousands) | 3,502 | 3,502 | 3,502 | 3,502 | 3,502 | 3,502 |
Reference price 2 | 48.35 | 21.25 | 20.90 | 55.35 | 80.50 | 384.0 |
Announcement Date | 8/13/18 | 9/3/19 | 9/8/20 | 9/4/21 | 9/5/22 | 9/4/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 81.46 | 68.29 | 61.5 | 47.31 | 28.5 | 1,165 |
EBITDA 1 | 43.71 | 42.51 | 25.96 | 31.15 | 19.64 | 46.36 |
EBIT 1 | 43.02 | 42.01 | 25.55 | 30.61 | 17.22 | 25.69 |
Operating Margin | 52.81% | 61.52% | 41.54% | 64.69% | 60.42% | 2.2% |
Earnings before Tax (EBT) 1 | 13.02 | 22.05 | 15.17 | 27.57 | 13.59 | 200 |
Net income 1 | 7.185 | 15.67 | 10.8 | 16.97 | 9.657 | 207.2 |
Net margin | 8.82% | 22.94% | 17.57% | 35.87% | 33.88% | 17.78% |
EPS 2 | 2.052 | 4.475 | 3.085 | 4.846 | 2.758 | 59.17 |
Free Cash Flow 1 | 97.62 | 17.25 | 275.9 | -218.9 | 212.4 | -387.1 |
FCF margin | 119.84% | 25.27% | 448.57% | -462.63% | 745.17% | -33.22% |
FCF Conversion (EBITDA) | 223.35% | 40.59% | 1,062.8% | - | 1,081.51% | - |
FCF Conversion (Net income) | 1,358.6% | 110.12% | 2,553.33% | - | 2,199.22% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/13/18 | 9/3/19 | 9/8/20 | 9/4/21 | 9/5/22 | 9/4/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 216 | 99.6 | - | - | 1.63 | 295 |
Net Cash position 1 | - | - | 18 | 88.1 | - | - |
Leverage (Debt/EBITDA) | 4.951 x | 2.343 x | - | - | 0.083 x | 6.373 x |
Free Cash Flow 1 | 97.6 | 17.3 | 276 | -219 | 212 | -387 |
ROE (net income / shareholders' equity) | 1.25% | 2.67% | 1.79% | 2.75% | 1.53% | 10.8% |
ROA (Net income/ Total Assets) | 2.83% | 3.21% | 2.06% | 2.57% | 1.52% | 0.68% |
Assets 1 | 254 | 488.4 | 524.2 | 660 | 633.8 | 30,401 |
Book Value Per Share 2 | 165.0 | 170.0 | 174.0 | 179.0 | 182.0 | 677.0 |
Cash Flow per Share 2 | 2.250 | 2.380 | 7.540 | 37.40 | 5.780 | 3.460 |
Capex | - | - | - | - | 22.9 | 56 |
Capex / Sales | - | - | - | - | 80.28% | 4.81% |
Announcement Date | 8/13/18 | 9/3/19 | 9/8/20 | 9/4/21 | 9/5/22 | 9/4/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+43.99% | 99.26M | |
+21.90% | 17.98B | |
+32.37% | 17.07B | |
+8.58% | 9.44B | |
-20.73% | 7.68B | |
+10.81% | 6.82B | |
+66.49% | 5.51B | |
-3.18% | 4.73B | |
+71.76% | 4.7B | |
+0.89% | 4.47B |
- Stock Market
- Equities
- IMCAP6 Stock
- Financials IM+ Capitals Limited